← FDA DRUG APPROVALS

FDA ANDA · ANDA072539

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE

Sponsor: WATSON LABS

APPLICATION
ANDA072539
TYPE
ANDA
ORIGINAL APPROVAL
1989-02-15
LATEST ACTION
1996-04-11
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDEDiscontinued
AMITRIPTYLINE HYDROCHLORIDE 10MG, PERPHENAZINE 2MG · TABLET · ORAL

Approval history

1996-04-11Labeling · Supplement 5AP
1993-11-04Labeling · Supplement 4AP
1989-05-31Labeling · Supplement 1AP
1989-02-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →